|
 |
|
|
| |
|
|
|
|
| Table 9. Estimated numbers of persons living with
HIV/AIDS at the end of 2004, by race/ethnicity, sex, and
transmission category—35 areas with confidential
name-based HIV infection reporting |
|
|
|
|
View PDF
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
| |
American |
|
| |
White, not |
Black, Not |
|
Asian/Pacific |
Indian/Alaska |
|
| |
Hispanic |
Hispanic |
Hispanic |
Islander |
Native |
Totala |
| Transmission Category |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
| Male adult or adolescent |
| Male-to-male sexual contact |
101,119 |
76 |
63,112 |
46 |
31,412 |
54 |
1,415 |
66 |
879 |
61 |
199,085 |
60 |
| Injection drug use |
12,750 |
10 |
33,237 |
24 |
14,990 |
26 |
267 |
12 |
218 |
15 |
61,799 |
19 |
| Male-to-male sexual contact and injection drug use |
10,667 |
8 |
9,030 |
7 |
3,237 |
6 |
74 |
3 |
191 |
13 |
23,337 |
7 |
| Heterosexual contact |
6,260 |
5 |
29,458 |
22 |
8,109 |
14 |
334 |
16 |
146 |
10 |
44,655 |
13 |
| Otherb |
1,580 |
1 |
1,617 |
1 |
411 |
1 |
50 |
2 |
18 |
1 |
3,702 |
1 |
| Subtotal |
132,376 |
100 |
136,454 |
100 |
58,159 |
100 |
2,141 |
100 |
1,452 |
100 |
332,578 |
100 |
| Female adult
or adolescent |
| Injection drug use |
8,104 |
34 |
19,554 |
25 |
5,521 |
30 |
96 |
16 |
168 |
32 |
33,621 |
27 |
| Heterosexual contact |
15,256 |
64 |
57,991 |
73 |
12,636 |
68 |
470 |
79 |
347 |
66 |
87,262 |
71 |
| Otherb |
481 |
2 |
1,626 |
2 |
357 |
2 |
30 |
5 |
10 |
2 |
2,523 |
2 |
| Subtotal |
23,841 |
100 |
79,170 |
100 |
18,513 |
100 |
596 |
100 |
525 |
100 |
123,405 |
100 |
| Child (<13
yrs at diagnosis) |
| Perinatal |
793 |
83 |
4,013 |
91 |
1,228 |
90 |
23 |
85 |
18 |
95 |
6,100 |
90 |
| Otherc |
161 |
17 |
389 |
9 |
138 |
10 |
4 |
15 |
1 |
5 |
704 |
10 |
| Subtotal |
953 |
100 |
4,402 |
100 |
1,366 |
100 |
27 |
100 |
19 |
100 |
6,804 |
100 |
| Totald |
157,172 |
220,028 |
78,039 |
2,765 |
1,996 |
462,792 |
|
|
|
|
| Note. These
numbers do not represent reported case counts. Rather, these
numbers are point estimates, which result from adjustments of
reported case counts. The reported case counts are adjusted for
reporting delays and for redistribution of cases in persons initially
reported without an identified risk factor. The estimates do
not include adjustment for incomplete reporting. |
| Data include persons
with a diagnosis of HIV infection. This includes persons with
a diagnosis of HIV infection only, a diagnosis of HIV infection
and a later AIDS diagnosis, and concurrent diagnoses of HIV infection
and AIDS. |
| Since 2000, the following
35 areas have had laws or regulations requiring confidential
name-based HIV infection reporting: Alabama, Alaska, Arizona,
Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana,
Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada,
New Jersey, New Mexico, New York, North Carolina, North Dakota,
Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas,
Utah, Virginia, West Virginia, Wisconsin, Wyoming, Guam and the
U.S. Virgin Islands. Since July 1997, Florida has had confidential
name-based HIV infection reporting only for new diagnoses. |
| a |
Includes 2,793 persons of unknown race
or multiple races. |
| b |
Includes hemophilia, blood transfusion,
perinatal, and risk factor not reported or not identified. |
| c |
Includes hemophilia, blood transfusion,
and risk factor not reported or not identified. |
| d |
Includes 5 persons of unknown sex. Because
column totals were calculated independently of the values
for the subpopulations, the values in each column may not
sum to the column total. | | |
| | |
|
|
|
|
|
|
